Common factors among Alzheimer’s disease, Parkinson’s disease, and epilepsy: Possible role of the noradrenergic nervous system
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary: The neurodegenerative disorders Alzheimer’s disease (AD) and Parkinson’s disease (PD) share in common the neuropathologic loss of locus coeruleus (LC) noradrenergic neurons. In addition, these two neurodegenerative disorders share two symptoms that define these disorders: cognitive impairment and depression. The hippocampus is a region that is known to play a role in cognition and depression, and the hippocampus receives sole noradrenergic innervation from LC neurons. However, it is unclear how the loss of LC noradrenergic neurons contributes to these common symptoms in these two disorders. Epilepsy is not considered a neurodegenerative disorder, but the hippocampus is severely affected in temporal lobe epilepsy. Of interest, cognitive impairment and depression are also common comorbid disorders in temporal lobe epilepsy. This article describes common symptoms among these three neurologic disorders and a possible role of the noradrenergic nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 2×
“Recent studies indicate that the loss of LC noradrenergic neurons may occur early in the progression of AD (Braak & Tredici, 2011; Braak et al., 2011), before the onset of cognitive impairment.”
BackgroundPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 1×
“In these mice, epileptiform activity and nonconvulsive seizures are observed in the cortex and hippocampus (Palop et al., 2007).”
BackgroundAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Ab protein and amyloid precursor protein have also been shown to control neuronal excitability (Kamenetz et al., 2003).”
Relating Hippocampal Circuitry to Function
Lisman, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)81085-5 · Cited by 607
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573 · cited 1×
“…1999; Weinshenker & Szot, 2002; Zarow et al., 2003; Szot et al., 2006; Fitzgerald, 2010a; McMillan et al., 2011), posttraumatic stress disorder (PTSD) (Southwick et al., 1999; Raskind et al., Address correspondence to Patricia Szot, 1660 S Columbian Way, MIRECC, Seattle, WA 98108, U.S.A. E-mail:…”
BackgroundLocus coeruleus and regulation of behavioral flexibility and attention
(2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26013-5 · Cited by 400
Seizures and Epilepsy in Alzheimer's Disease
Friedman, D., Honig, L. S., & Scarmeas, N. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00251.x · Cited by 229
Cited by
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Exercise Benefits Brain Function: The Monoamine Connection
Lin, T.-W., & Kuo, Y.-M. (2013) · Brain Sciences · doi:10.3390/brainsci3010039 · Cited by 392
“Loss of noradrenergic neurons in locus coeruleus has been implied to be involved in the symptoms of cognitive impairment in PD and Alzheimer’s disease [105,106].”
BackgroundMonzani, E., Nicolis, S., Dell'Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 271
Tau-induced pathology in epilepsy and dementia: notions from patients and animal models.
Sánchez, M., García-Cabrero, A., Sánchez-Elexpuru, G., Burgos, D., & Serratosa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041092 · Cited by 68
“The hippocampus of patients with AD and epilepsy shows similar pathologies, like circuitry reorganization and loss of hippocampal neurons [61].”
BackgroundGulyaeva, N. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921060031 · Cited by 54
Complicated Role of Exercise in Modulating Memory: A Discussion of the Mechanisms Involved
Ebrahimnejad, M., Azizi, P., Alipour, V., Zarrindast, M.-R., & Vaseghi, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03552-w · Cited by 21
“Also, loss of noradrenergic neurons in the locus coeruleus is related to the symptoms of cognitive impairment in Parkinson’s disease [130] and AD [131].”
Background
Metadata
- Authors
- Szot, P.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2012-05-21
- Volume
- 53
- Issue
- s1
- Pages
- 61-66
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1597859722
- Cited by
- 87
- References
- 7
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.